2022
Genetics of monogenic disorders of calcium and bone metabolism (Journal article)
Newey, P. J., Hannan, F. M., Wilson, A., & Thakker, R. V. (2022). Genetics of monogenic disorders of calcium and bone metabolism. CLINICAL ENDOCRINOLOGY, 97(4), 483-501. doi:10.1111/cen.14644DOI: 10.1111/cen.14644
2021
Asymmetric activation of the calcium-sensing receptor homodimer. (Journal article)
Gao, Y., Robertson, M. J., Rahman, S. N., Seven, A. B., Zhang, C., Meyerowitz, J. G., . . . Skiniotis, G. (2021). Asymmetric activation of the calcium-sensing receptor homodimer.. Nature, 595(7867), 455-459. doi:10.1038/s41586-021-03691-0DOI: 10.1038/s41586-021-03691-0
2020
International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function (Journal article)
Leach, K., Hannan, F. M., Josephs, T. M., Keller, A. N., Moller, T. C., Ward, D. T., . . . Brauner-Osborne, H. (2020). International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function. PHARMACOLOGICAL REVIEWS, 72(3), 558-604. doi:10.1124/pr.119.018531DOI: 10.1124/pr.119.018531
Dershem, R., Gorvin, C. M., Metpally, R. P. R., Krishnamurthy, S., Smelser, D. T., Hannan, F. M., . . . Breitwieser, G. E. (2020). Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population. AMERICAN JOURNAL OF HUMAN GENETICS, 106(6), 734-747. doi:10.1016/j.ajhg.2020.04.006DOI: 10.1016/j.ajhg.2020.04.006
Dharmaraj, P., Gorvin, C. M., Soni, A., Nelhans, N. D., Olesen, M. K., Boon, H., . . . Hannan, F. M. (2020). Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1). JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 105(5). doi:10.1210/clinem/dgaa111DOI: 10.1210/clinem/dgaa111
Gorvin, C. M., Stokes, V. J., Boon, H., Cranston, T., Gluck, A. K., Bahl, S., . . . Thakker, R. V. (2020). Activating Mutations of the G-protein Subunit a 11 Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 105(3), 952-963. doi:10.1210/clinem/dgz251DOI: 10.1210/clinem/dgz251
2019
Bollerslev, J., Schalin-Jantti, C., Rejnmark, L., Siggelkow, H., Morreau, H., Thakker, R., . . . Vestergard, P. (2019). Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT). EUROPEAN JOURNAL OF ENDOCRINOLOGY, 181(3), P1-P19. doi:10.1530/EJE-19-0316DOI: 10.1530/EJE-19-0316
Gorvin, C. M., Loh, N. Y., Stechman, M. J., Falcone, S., Hannan, F. M., Ahmad, B. N., . . . Thakker, R. V. (2019). Mice with a Brd4 Mutation Represent a New Model of Nephrocalcinosis. JOURNAL OF BONE AND MINERAL RESEARCH, 34(7), 1324-1335. doi:10.1002/jbmr.3695DOI: 10.1002/jbmr.3695
Hannan, F. M., Newey, P. J., Whyte, M. P., & Thakker, R. V. (2019). Genetic approaches to metabolic bone diseases. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 85(6), 1147-1160. doi:10.1111/bcp.13803DOI: 10.1111/bcp.13803
Genetic regulation of parathyroid gland development (Chapter)
Hannan, F. M., & Thakker, R. V. (2020). Genetic regulation of parathyroid gland development. In Principles of Bone Biology (pp. 1355-1377). Elsevier. doi:10.1016/b978-0-12-814841-9.00056-7DOI: 10.1016/b978-0-12-814841-9.00056-7
2018
Hannan, F. M., Kallay, E., Chang, W., Brandi, M. L., & Thakker, R. V. (2018). The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. NATURE REVIEWS ENDOCRINOLOGY, 15(1), 33-51. doi:10.1038/s41574-018-0115-0DOI: 10.1038/s41574-018-0115-0
Hannan, F. M., Olesen, M. K., & Thakker, R. V. (2018). Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway. BRITISH JOURNAL OF PHARMACOLOGY, 175(21), 4083-4094. doi:10.1111/bph.14086DOI: 10.1111/bph.14086
Gorvin, C. M., Frost, M., Malinauskas, T., Cranston, T., Boon, H., Siebold, C., . . . Thakker, R. V. (2018). Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias. HUMAN MOLECULAR GENETICS, 27(21), 3720-3733. doi:10.1093/hmg/ddy263DOI: 10.1093/hmg/ddy263
Gorvin, C. M., Metpally, R., Stokes, V. J., Hannan, F. M., Krishnamurthy, S. B., Overton, J. D., . . . Thakker, R. V. (2018). Large-scale exome datasets reveal a new class of adaptor-related protein complex 2 sigma subunit (AP2σ) mutations, located at the interface with the AP2 alpha subunit, that impair calcium-sensing receptor signalling. HUMAN MOLECULAR GENETICS, 27(5), 901-911. doi:10.1093/hmg/ddy010DOI: 10.1093/hmg/ddy010
Gorvin, C. M., Babinsky, V. N., Malinauskas, T., Nissen, P. H., Schou, A. J., Hanyaloglu, A. C., . . . Thakker, R. V. (2018). A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate beta-arrestin-biased signaling. SCIENCE SIGNALING, 11(518). doi:10.1126/scisignal.aan3714DOI: 10.1126/scisignal.aan3714
Gorvin, C. M., Hannan, F. M., Cranston, T., Valta, H., Makitie, O., Schalin-Jantti, C., & Thakker, R. V. (2018). Cinacalcet rectifies hypercalcemia in a patient with familial hypocalciuric hypercalcemia type 2 (FHH2) caused by a germline loss-of-function Gα 11 mutation. Journal of Bone and Mineral Research, 31(01), 32-41. doi:10.1002/jbmr.3241DOI: 10.1002/jbmr.3241
Hypoparathyroidism (Chapter)
Hannan, F. M., & Thakker, R. V. (2018). Hypoparathyroidism. In Genetics of Bone Biology and Skeletal Disease (pp. 617-636). Elsevier. doi:10.1016/b978-0-12-804182-6.00034-4DOI: 10.1016/b978-0-12-804182-6.00034-4
Goljanek-Whysall, K., Tridimas, A., McCormick, R., Russell, N. -J., Sloman, M., Sorani, A., . . . Hannan, F. M. (2018). Identification of a novel loss-of-function PHEX mutation, Ala720Ser, in a sporadic case of adult-onset hypophosphatemic osteomalacia. Bone, 106, 30-34. doi:10.1016/j.bone.2017.10.002DOI: 10.1016/j.bone.2017.10.002
2017
Stokes, V. J., Nielsen, M. F., Hannan, F. M., & Thakker, R. V. (2017). Hypercalcemic Disorders in Children. JOURNAL OF BONE AND MINERAL RESEARCH, 32(11), 2157-2170. doi:10.1002/jbmr.3296DOI: 10.1002/jbmr.3296
Howles, S. A., Hannan, F. M., Gorvin, C. M., Piret, S. E., Paudyal, A., Stewart, M., . . . Thakker, R. V. (2017). Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation. JCI insight, 2(20). doi:10.1172/jci.insight.96540DOI: 10.1172/jci.insight.96540
Hypoparathyroidism. (Journal article)
Mannstadt, M., Bilezikian, J. P., Thakker, R. V., Hannan, F. M., Clarke, B. L., Rejnmark, L., . . . Shoback, D. M. (2017). Hypoparathyroidism.. Nature reviews. Disease primers, 3, 17080. doi:10.1038/nrdp.2017.80DOI: 10.1038/nrdp.2017.80
Mannstadt, M., Bilezikian, J. P., Thakker, R. V., Hannan, F. M., Clarke, B. L., Reijnmark, L., . . . Shoback, D. M. (2017). Hypoparathyroidism. NATURE REVIEWS DISEASE PRIMERS, 3. doi:10.1038/nrdp.2017.55DOI: 10.1038/nrdp.2017.55
Babinsky, V. N., Hannan, F. M., Ramracheya, R. D., Zhang, Q., Nesbit, M. A., Hugill, A., . . . Thakker, R. V. (2017). Mutant mice with calcium-sensing receptor activation have hyperglycemia, that is rectified by calcilytic therapy.. Endocrinology, 158(8), 2486-2502. doi:10.1210/en.2017-00111DOI: 10.1210/en.2017-00111
Gorvin, C. M., Hannan, F. M., Howles, S. A., Babinsky, V. N., Piret, S. E., Rogers, A., . . . Thakker, R. V. (2017). Gα<sub>11</sub> mutation in mice causes hypocalcemia rectifiable by calcilytic therapy. JCI INSIGHT, 2(3). doi:10.1172/jci.insight.91103
2016
Hannan, F. M., Babinsky, V. N., & Thakker, R. V. (2016). Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 57(3), R127-R142. doi:10.1530/JME-16-0124DOI: 10.1530/JME-16-0124
G-Protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causing Familial Hypocalciuric Hypercalcemia Type 2 (FHH2). (Journal article)
Gorvin, C. M., Cranston, T., Hannan, F., Rust, N., Qureshi, A., Nesbit, M. A., & Thakker, R. V. (2016). G-Protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causing Familial Hypocalciuric Hypercalcemia Type 2 (FHH2).. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 31(6), 1200-1206. doi:10.1002/jbmr.2778DOI: 10.1002/jbmr.2778
Piret, S. E., Gorvin, C. M., Pagnamenta, A. T., Howles, S. A., Cranston, T., Rust, N., . . . Thakker, R. V. (2016). Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family with Autosomal Dominant Hypocalcemia Type 2 (ADH2).. Journal of Bone and Mineral Research, 31(6), 1207-1214. doi:10.1002/jbmr.2797DOI: 10.1002/jbmr.2797
Babinsky, V. N., Hannan, F. M., Gorvin, C. M., Howles, S. A., Nesbit, M. A., Rust, N., . . . Thakker, R. V. (2016). Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders. Journal of Biological Chemistry, 291(20), 10876-10885. doi:10.1074/jbc.M115.696401DOI: 10.1074/jbc.M115.696401
Howles, S. A., Hannan, F. M., Babinsky, V. N., Rogers, A., Gorvin, C. M., Rust, N., . . . McKenna, M. J. (2016). Cinacalcet for Symptomatic Hypercalcemia Caused by <i>AP2S1</i> Mutations. NEW ENGLAND JOURNAL OF MEDICINE, 374(14), 1396-1398. doi:10.1056/NEJMc1511646DOI: 10.1056/NEJMc1511646
2015
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype–phenotype correlations, codon bias and dominant-negative effects (Journal article)
Hannan, F. M., Howles, S. A., Rogers, A., Cranston, T., Gorvin, C. M., Babinsky, V. N., . . . Thakker, R. V. (2015). Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype–phenotype correlations, codon bias and dominant-negative effects. Human Molecular Genetics, 24(18), 5079-5092. doi:10.1093/hmg/ddv226DOI: 10.1093/hmg/ddv226
The calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing-receptor (CaSR) mutation: relevance to autosomal dominant hypocalcemia type 1 (ADH1) (Journal article)
Hannan, F., Walls, G. V., Babinsky, V. N., Nesbit, M. A., Kallay, E., Hough, T. A., . . . Thakker, R. V. (2015). The calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing-receptor (CaSR) mutation: relevance to autosomal dominant hypocalcemia type 1 (ADH1). Endocrinology, 156(09), 3114-3121. doi:10.1210/en.2015-1269DOI: 10.1210/en.2015-1269
Esapa, C. T., Hannan, F., Babinsky, V. N., Potter, P., Thomas, G. P., Croucher, P. I., . . . Thakker, R. V. (2015). N-ethyl-N-Nitrosourea (ENU) induced mutations within the klotho gene lead to ectopic calcification and reduced lifespan in mouse models. PloS ONE, 10(4). doi:10.1371/journal.pone.0122650DOI: 10.1371/journal.pone.0122650
Babinsky, V. N., Hannan, F., Youhanna, S. C., Maréchal, C., Jadoul, M., Devuyst, O., & Thakker, R. V. (2015). Association Studies of Calcium-Sensing Receptor (CaSR) Polymorphisms with Serum Concentrations of Glucose and Phosphate, and Vascular Calcification in Renal Transplant Recipients. PLOS ONE, 10(3). doi:10.1371/journal.pone.0119459DOI: 10.1371/journal.pone.0119459
2014
Zhang, C., Mulpuri, N., Hannan, F. M., Nesbit, M. A., Thakker, R. V., Hamelberg, D., . . . Yang, J. J. (2014). Role of Ca2+ and L-Phe in Regulating Functional Cooperativity of Disease-Associated "Toggle" Calcium-Sensing Receptor Mutations. PLoS ONE, 9(11). doi:10.1371/journal.pone.0113622DOI: 10.1371/journal.pone.0113622
Mutational Analysis of the Adaptor Protein 2 Sigma Subunit (AP2S1) Gene: Search for Autosomal Dominant Hypocalcemia Type 3 (ADH3) (Journal article)
Rogers, A., Nesbit, M. A., Hannan, F. M., Howles, S. A., Gorvin, C. M., Cranston, T., . . . Thakker, R. V. (2014). Mutational Analysis of the Adaptor Protein 2 Sigma Subunit (AP2S1) Gene: Search for Autosomal Dominant Hypocalcemia Type 3 (ADH3). Journal of Clinical Endocrinology and Metabolism, 99(7), E1300-E1305. doi:10.1210/jc.2013-3909DOI: 10.1210/jc.2013-3909
An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess (Journal article)
Bentley, L., Esapa, C. T., Nesbit, M. A., Head, R. A., Evans, H., Lath, D., . . . Thakker, R. V. (2014). An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess. Endocrinology, 155(3), 908-922. doi:10.1210/en.2013-1247DOI: 10.1210/en.2013-1247
2013
Mutations Affecting G-Protein Subunit α<sub>11</sub> in Hypercalcemia and Hypocalcemia (Journal article)
Nesbit, M. A., Hannan, F. M., Howles, S. A., Babinsky, V. N., Head, R. A., Cranston, T., . . . Thakker, R. V. (2013). Mutations Affecting G-Protein Subunit α<sub>11</sub> in Hypercalcemia and Hypocalcemia. NEW ENGLAND JOURNAL OF MEDICINE, 368(26), 2476-2486. doi:10.1056/NEJMoa1300253DOI: 10.1056/NEJMoa1300253
Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism (Journal article)
Hannan, F. M., & Thakker, R. V. (2013). Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 27(3), 359-371. doi:10.1016/j.beem.2013.04.007DOI: 10.1016/j.beem.2013.04.007
RATIONAL TESTING Investigating hypocalcaemia (Journal article)
Hannan, F. M., & Thakker, R. V. (2013). RATIONAL TESTING Investigating hypocalcaemia. BMJ-BRITISH MEDICAL JOURNAL, 346. doi:10.1136/bmj.f2213DOI: 10.1136/bmj.f2213
Autosomal Dominant Hypercalciuria in a Mouse Model Due to a Mutation of the Epithelial Calcium Channel, TRPV5 (Journal article)
Loh, N. Y., Bentley, L., Dimke, H., Verkaart, S., Tammaro, P., Gorvin, C. M., . . . Thakker, R. V. (2013). Autosomal Dominant Hypercalciuria in a Mouse Model Due to a Mutation of the Epithelial Calcium Channel, TRPV5. PLOS ONE, 8(1). doi:10.1371/journal.pone.0055412DOI: 10.1371/journal.pone.0055412
Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism (Journal article)
Hannan, F. M., & Thakker, R. V. (2013). Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best Practice and Research: Clinical Endocrinology and Metabolism, 27(3), 359-371. doi:10.1016/j.beem.2013.04.007DOI: 10.1016/j.beem.2013.04.007
Mutations in <i>AP2S1</i> cause familial hypocalciuric hypercalcemia type 3 (Journal article)
Nesbit, M. A., Hannan, F. M., Howles, S. A., Reed, A. A. C., Cranston, T., Thakker, C. E., . . . Thakker, R. V. (2013). Mutations in <i>AP2S1</i> cause familial hypocalciuric hypercalcemia type 3. NATURE GENETICS, 45(1), 93-U135. doi:10.1038/ng.2492DOI: 10.1038/ng.2492
2012
Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites (Journal article)
Hannan, F. M., Nesbit, M. A., Zhang, C., Cranston, T., Curley, A. J., Harding, B., . . . Thakker, R. V. (2012). Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. HUMAN MOLECULAR GENETICS, 21(12), 2768-2778. doi:10.1093/hmg/dds105DOI: 10.1093/hmg/dds105
2010
A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia (Journal article)
Hannan, F. M., Nesbit, M. A., Christie, P. T., Lissens, W., Van der Schueren, B., Bex, M., . . . Thakker, R. V. (2010). A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia. CLINICAL ENDOCRINOLOGY, 73(6), 715-722. doi:10.1111/j.1365-2265.2010.03870.xDOI: 10.1111/j.1365-2265.2010.03870.x
Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6Mb containing four mouse calcium-sensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3 (Journal article)
Hannan, F. M., Nesbit, M. A., Turner, J. J. O., Stacey, J. M., Cianferotti, L., Christie, P. T., . . . Thakker, R. V. (2010). Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6Mb containing four mouse calcium-sensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3. EUROPEAN JOURNAL OF HUMAN GENETICS, 18(4), 442-447. doi:10.1038/ejhg.2009.161DOI: 10.1038/ejhg.2009.161
Identification of a Second Kindred with Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Narrows Localization to a <3.5 Megabase Pair Region on Chromosome 19q13.3 (Journal article)
Nesbit, M. A., Hannan, F. M., Graham, U., Whyte, M. P., Morrison, P. J., Hunter, S. J., & Thakker, R. V. (2010). Identification of a Second Kindred with Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Narrows Localization to a <3.5 Megabase Pair Region on Chromosome 19q13.3. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 95(4), 1947-1954. doi:10.1210/jc.2009-2152DOI: 10.1210/jc.2009-2152
2008
Oncogenic hypophosphataemic osteomalacia:: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D<sub>3</sub> and lymphatic vessel endothelial hyaluronan receptor 1 (Journal article)
Hannan, F. M., Athanasoul, N. A., Teh, J., Gibbons, C. L. M. H., Shine, B., & Thakker, R. V. (2008). Oncogenic hypophosphataemic osteomalacia:: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D<sub>3</sub> and lymphatic vessel endothelial hyaluronan receptor 1. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 158(2), 265-271. doi:10.1530/EJE-07-0485DOI: 10.1530/EJE-07-0485
Familial isolated primary hyperparathyroidism caused by mutations of the <i>MEN1</i> gene (Journal article)
Hannan, F. M., Nesbit, M. A., Christie, P. T., Fratter, C., Dudley, N. E., Sadler, G. P., & Thakker, R. V. (2008). Familial isolated primary hyperparathyroidism caused by mutations of the <i>MEN1</i> gene. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 4(1), 53-58. doi:10.1038/ncpendmet0718DOI: 10.1038/ncpendmet0718
2006
Functional characterization of calcium sensing receptor polymorphisms and absence of association with indices of calcium homeostasis and bone mineral density (Journal article)
Harding, B., Curley, A. J., Hannan, F. M., Christie, P. T., Bowl, M. R., Turner, J. J. O., . . . Thakker, R. V. (2006). Functional characterization of calcium sensing receptor polymorphisms and absence of association with indices of calcium homeostasis and bone mineral density. CLINICAL ENDOCRINOLOGY, 65(5), 598-605. doi:10.1111/j.1365-2265.2006.02634.xDOI: 10.1111/j.1365-2265.2006.02634.x
2004
Vitamin D deficiency masking primary hyperparathyroidism (Journal article)
Hannan, F. M., Fairney, A., & Johnston, D. G. (2004). Vitamin D deficiency masking primary hyperparathyroidism. ANNALS OF CLINICAL BIOCHEMISTRY, 41, 405-407. doi:10.1258/0004563041731619DOI: 10.1258/0004563041731619
2003
Update on the management of asymptomatic primary hyperparathyroidism (Journal article)
Hannan, F. M., & Fairney, A. (2003). Update on the management of asymptomatic primary hyperparathyroidism. CPD Bulletin Clinical Biochemistry, 5(2), 53-55.
2002
Recent advances in the understanding of parathyroid gland function and primary hyperparathyroidism (Journal article)
Hannan, F. M., & Fairney, A. (2002). Recent advances in the understanding of parathyroid gland function and primary hyperparathyroidism. CPD Bulletin Clinical Biochemistry, 4(3), 71-73.
2001
se of nicotinic acid in the management of recurrent hypoglycemic episodes in diabetes (Journal article)
Hannan, F., & Davoren, P. (2001). se of nicotinic acid in the management of recurrent hypoglycemic episodes in diabetes. Diabetes Care, 24(7), 1301.